Combination Treatment with Intravesical Interferon-Alpha Gene Therapy and Oral Pan-ErbB Receptor Family Blocker Improves Survival in Mice with Bladder Cancer
Akshay Sood, Alberto Martini, Paulo Genitiano…·Sharada Mokkapati
This paper shows that combining intravesical IFN gene therapy with oral Afatinib improves survival in mice with bladder cancer by targeting the ErbB resistance pathway.